Free Trial

SOPHiA GENETICS Q1 2024 Earnings Report

SOPHiA GENETICS logo
$3.17 -0.15 (-4.52%)
As of 04:00 PM Eastern

SOPHiA GENETICS EPS Results

Actual EPS
-$0.21
Consensus EPS
-$0.25
Beat/Miss
Beat by +$0.04
One Year Ago EPS
N/A

SOPHiA GENETICS Revenue Results

Actual Revenue
$15.78 million
Expected Revenue
$16.80 million
Beat/Miss
Missed by -$1.02 million
YoY Revenue Growth
N/A

SOPHiA GENETICS Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Remove Ads

SOPHiA GENETICS Earnings Headlines

Morgan Stanley Keeps Their Hold Rating on SOPHiA GENETICS (SOPH)
SOPHiA GENETICS (SOPH) Gets a Buy from BTIG
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
SOPHiA GENETICS (SOPH) Receives a Buy from BTIG
See More SOPHiA GENETICS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SOPHiA GENETICS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SOPHiA GENETICS and other key companies, straight to your email.

About SOPHiA GENETICS

SOPHiA GENETICS (NASDAQ:SOPH) operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

View SOPHiA GENETICS Profile

More Earnings Resources from MarketBeat